title: The relationship of corneal epithelial defect size to drug penetration.
abstract: OBJECTIVE
  To determine the relationship between corneal epithelial defect size and corneal penetration of a triazole antifungal drug in an animal model.
  
  
  METHODS
  Corneas of adult rabbits were débrided of epithelium 25%, 50%, 75%, or 100% of surface area; the untreated fellow eye served as a control. Tritiated saperconazole was applied to each cornea every 5 minutes for 1 hour. The animals were killed and the cornea and aqueous of each eye were assayed for radiolabel activity.
  
  
  RESULTS
  Removal of 25% of the corneal epithelium produced an increase in corneal saperconazole concentration compared with eyes with intact epithelium. Increasing epithelial defect size from 25% to 50% produced a ninefold increase in mean corneal drug concentration (P = .0001). There was no further increase in corneal drug levels in eyes with 75% or 100% epithelial defects. A similar threshold effect was observed in aqueous drug concentration between 25% and 50% débridement (P = .0001).
  
  
  CONCLUSIONS
  In this experimental model, an apparent threshold was noted between 25% and 50% epithelial defect area, beyond which larger defects did not significantly increase drug penetration into the cornea or aqueous. This may be of clinical benefit in circumstances in which epithelial débridement is considered to enhance drug penetration.
authors.affiliation: Department of Ophthalmology and Visual Sciences, Vanderbilt University School of Medicine, Nashville, Tenn., USA.
authors.forename: D A
authors.initials: DA
authors.lastname: Johnson
authors.forename: K J
authors.initials: KJ
authors.lastname: Johns
authors.forename: R D
authors.initials: RD
authors.lastname: Robinson
authors.forename: W S
authors.initials: WS
authors.lastname: Head
authors.forename: D M
authors.initials: DM
authors.lastname: O'Day
mesh_terms: D000818:Animals; D000867:Anterior Chamber / Q000378:metabolism; D000935:Antifungal Agents / Q000493:pharmacokinetics*; D001082:Aqueous Humor / Q000378:metabolism; D001393:Azoles / Q000493:pharmacokinetics*; D003315:Cornea / Q000378:metabolism* / Q000473:pathology; D003316:Corneal Diseases / Q000378:metabolism* / Q000473:pathology; D004848:Epithelium / Q000378:metabolism / Q000473:pathology; D011817:Rabbits; D014018:Tissue Distribution
chemical_list: D000935:Antifungal Agents; D001393:Azoles; C060571:saperconazole